EBS
EBS
US29089Q1058
Emergent BioSolutions Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 705.200.000 1.013.600.000
30.4%
Cost of Revenue 326.200.000 681.300.000
52.1%
Gross Profit 379.000.000 332.300.000
14.1%
266.700.000 413.800.000
35.5%
Operating Income 112.300.000 -81.500.000
237.8%
Pretax Income 82.800.000 -142.900.000
157.9%
Net Income Common Stockholders 52.600.000 -190.600.000
127.6%
-- --
--
-- --
--
ende